drugset / Trial / NCT01073826

Role of Interleukin-6 in Exercise

NCT01073826

RandomizedParallel-groupQuadruple-blindPrevention

Summary

The purpose of the study is to understand the role of interleukin-6 during physical activity in patients with type 2 diabetes.

Timeline

Start
2010-02
Primary completion
2015-11
Completion
2016-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Sitagliptin Small molecule 100 mg Oral
Comparator Tocilizumab Monoclonal antibody 8 mg/kg Intravenous